half life of retatrutide New Phase 3 data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats BCBS VT nonsensical rationale rocket-hide Color:Pink and Gold Dual

half life of retatrutide New Phase 3 data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats BCBS VT nonsensical rationale rocket-hide Color:Pink and Gold Dual

BCBS VT nonsensical rationale for dropping GLP coverage : r/Zepbound

GLP-1 RAs have shown antitumor effects via metabolic and immune modulation, reduced incidence of obesity-related cancers, and improved outcomes in some patients

rocket-hide

Color:Pink and Gold Dual

Retatrutide is not approved by the FDA for human use and is sold strictly for laboratory research by qualified individuals.